Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| MAPK signaling pathway | R-HSA-9652817 | map04010 | diflunisal | 3059 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | diflunisal | 3059 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | diflunisal | 3059 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | diflunisal | 3059 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | diflunisal | 3059 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | diflunisal | 3059 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | diflunisal | 3059 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | diflunisal | 3059 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | hydrochlorothiazide | 441074 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | hydrochlorothiazide | 441074 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | hydrochlorothiazide | 441074 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | hydrochlorothiazide | 441074 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | captopril | 44093 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | captopril | 44093 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | captopril | 44093 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | captopril | 44093 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | captopril | 44093 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | captopril | 44093 | drug-path |
| Adherens junction | R-HSA-451386 | map04520 | acebutolol | 1978 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | acebutolol | 1978 | drug-path |